PVLA
PALVELLA THERAPEUTICS, INC.
Latest Form 4:Sale$655KbyGoin Kathleen (Chief Operating Officer) · filed Aug 20, 2026
PALVELLA THERAPEUTICS, INC. (PVLA) has 14 SEC Form 4 filings (54 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Aug 20, 2026.
The most active filer is Chief Operating Officer Goin Kathleen with 10 filings. Insiders have net sold $2.5M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Wesley H. Kaupinen
- Employees:29
- HQ:Wayne, PA, US
- IPO:2015-01-02
Insider Buying
$850K
reported purchases (SEC code P)
Insider Selling
$4.9M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
Market Cap
$2.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Operating Officer | Sale | 4,302 | $655K | Aug 20 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $642K | Jul 17 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $476K | Jun 22 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $476K | May 22 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $547K | Apr 17 | SEC ↗ | |
| Director | Purchase | 445 | $50K | Apr 1 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $508K | Mar 20 | SEC ↗ | |
HERON ELAINE JFirst in 3 months | Director | Purchase | 2,400 | $300K | Mar 2 | SEC ↗ |
JENKINS GEORGE MFirst filing | Director | Purchase | 4,000 | $500K | Mar 2 | SEC ↗ |
| Chief Operating Officer | Sale | 4,302 | $342K | Feb 20 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $420K | Jan 23 | SEC ↗ | |
| Chief Operating Officer | Sale | 4,302 | $415K | Dec 19 | SEC ↗ | |
Goin KathleenFirst filing | Chief Operating Officer | Sale | 4,302 | $371K | Nov 21 | SEC ↗ |
Related companies
PALVELLA THERAPEUTICS, INC. is in the Healthcare sector.